#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Rett syndrome Osteosarcoma recurrent Glomerulonephritis rapidly progressive Kearns-Sayre syndrome Mixed-type liposarcoma Immune-mediated enterocolitis Fusarium infection Neonatal asphyxia Microscopic polyangiitis Hypersomnia Pulmonary arterial hypertension Congenital aplastic anaemia Chronic granulomatous disease Hepato-lenticular degeneration Spinal cord injury More trials…

    Learn about Rare Diseases

    Haemophilia B with anti factor IX Ocular melanoma – Life with Disease Pemphigus – Life with Disease Ehlers-Danlos syndrome Ornithine transcarbamoylase deficiency – Basic Information Splenic marginal zone lymphoma – Basic Information Skin angiosarcoma Nodal marginal zone B-cell lymphoma – Diagnostics Von Willebrand’s disease – Treatment Alexander disease – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Febuxostat Hemihydrate Specific Nucleic Acid Sna-Papi Digoxin Immune Fab (Ovine) Ep0031 VRDN-003 Psma-11 CHLORMADINONE ACETATE Amphotericin B Annamycin 19Cp02 Azd3427 Idarubicin Hydrochloride Ucart22 Rocatinlimab Ambrisentan Capivasertib Daunorubicin Hydrochloride Av-Ec2023 Bp1.7881A Gad20-209-Fsp-A4 More therapies…

    Learn about Your Condition

    Cirrhosis alcoholic Adenocarcinoma gastric Intracranial aneurysm Oesophagectomy Retinoblastoma Asplenia Radicular pain Dilated cardiomyopathy Decreased appetite Ureteric cancer Stress Paget's disease of the vulva Hidradenitis Colon cancer stage IV Herpes simplex reactivation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of 177Lu-PSMA and Stereotactic Radiotherapy vs. Radiotherapy for Patients with Oligometastatic Prostate Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    Investigated Drugs:
    • 177LU-PSMA-I&T
    Italy

  • Studying the Effects of Deferiprone on Motor Function in Children with Pelizaeus-Merzbacher Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pelizaeus-Merzbacher disease
    Investigated Drugs:
    • Deferiprone
    The Netherlands

  • Study on the Effects of Sacubitril/Valsartan and Ramipril on Heart Function in Patients with Ischemic Heart Failure with Mid-Range Ejection Fraction

    Recruiting

    3 1 1
    Investigated Drugs:
    • Hydrochlorothiazide
    • Ramipril
    • Sacubitril
    Poland

  • Study on the Safety and Absorption of Meropenem and Vaborbactam in Children with Complicated Urinary Tract Infections

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pyelonephritis acute
    Investigated Drugs:
    • Vaborbactam
    • Meropenem
    Czechia France Italy Poland Spain

  • Study of oxytocin, dinoprostone, and misoprostol combination for active management in pregnant women with premature rupture of membranes

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Preterm premature rupture of membranes
    Investigated Drugs:
    • Dinoprostone
    • Mifepristone
    Italy

  • Study on Dapansutrile for Patients with Type 2 Diabetes Not Well Controlled on Standard Treatment

    Recruiting

    2 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Dapansutrile
    Belgium France Germany
Previous Page
1 … 289 290 291 292 293 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!